Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Identification, development and commercialization of meaningful pharmaceutical products that address4.07B100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States3.66B89.95%
Europe312.71M7.69%
All other96.14M2.36%